News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
163 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17879)
Month
January (2478)
February (2705)
March (2920)
April (2815)
May (3257)
June (3002)
July (2537)
August (2870)
September (2818)
October (3675)
November (3195)
December (2498)
Day
1 (222)
2 (216)
3 (175)
6 (112)
7 (214)
8 (163)
9 (211)
10 (133)
13 (189)
14 (183)
15 (144)
16 (127)
17 (123)
18 (2)
20 (134)
21 (140)
22 (127)
27 (173)
28 (145)
29 (148)
30 (114)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
6
7
8
9
10
13
14
15
16
17
18
20
21
22
27
28
29
30
Drug Development
Exelixis, Inc. Reports Additional Data From The Phase I Trial Of XL999 In Patients With Advanced Solid Tumors
November 8, 2006
·
8 min read
Business
Biovitrum AB Wins Contract To Manufacture Pharmaceutical Substance For Resistentia’s Clinical Phase III Trials Of New Protein-Based Drug Candidate For The Treatment Of Allergy
November 8, 2006
·
1 min read
Business
AVI BioPharma, Inc. Reports Third Quarter Financial Results
November 8, 2006
·
1 min read
SR Pharma PLC Places 20 Mln Shares At 19p/Shr Raising 3.8 Mln Stg
November 8, 2006
·
1 min read
Pharm Country
PharmaNet Development Group, Inc. To Present At The Stanford Growth Conference On Tuesday, November 14, 2006
November 8, 2006
·
1 min read
Genetown
Apogee Technology, Inc. Confirms That It Will Submit A Listing Plan To American Stock Exchange
November 8, 2006
·
1 min read
Business
Santarus Inc. Reports Third Quarter 2006 Financial Results
November 8, 2006
·
1 min read
Biotech Beach
MultiCell Technologies Inc. Posts Journal Article On Research Leading To Company’s Recent Patent Application On Novel Cancer Treatment
November 8, 2006
·
1 min read
Drug Development
First Patient Enrolled In OXiGENE’s Phase Ib Trial Of Its Lead Vascular Disrupting Agent, CA4P, In Combination With An Antiangiogenic Agent, Bevacizumab (Avastin) For The Treatment Of Advanced Cancer
November 8, 2006
·
1 min read
Biotech Beach
Hollis-Eden Pharmaceuticals Inc. To Raise $26.0 Million Through Sale Of Common Stock And Warrants
November 8, 2006
·
1 min read
Previous
10 of 17
Next
